Report Detail
Global Preclinical Oncology Models Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4519349 |
- 06 March, 2023 |
- Global |
- 104 Pages |
- GIR (Global Info Research) |
- Other
According to our (Global Info Research) latest study, the global Preclinical Oncology Models market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Preclinical Oncology Models market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Preclinical Oncology Models market size and forecasts, in consumption value ($ Million), 2018-2029
Global Preclinical Oncology Models market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Preclinical Oncology Models market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Preclinical Oncology Models market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Preclinical Oncology Models
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Preclinical Oncology Models market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aragen Bioscience, Vivopharm, Bioduro, Crown Bioscience and Charles River, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Preclinical Oncology Models market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Genetically Engineered Mouse Models (GEMMs)
Cell Line-derived Xenografts (CDX)
Patient-derived Xenografts (PDX)
Others
Market segment by Application
Pharmaceutical
Biological Experiments
Others
Market segment by players, this report covers
Aragen Bioscience
Vivopharm
Bioduro
Crown Bioscience
Charles River
Champion Oncology
Envigo
Genoway Sa
Hera Biolabs
Mi Bioresearch
Pharmatest Services
Taconic Biosciences
The Jackson Laboratory
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Preclinical Oncology Models product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Preclinical Oncology Models, with revenue, gross margin and global market share of Preclinical Oncology Models from 2018 to 2023.
Chapter 3, the Preclinical Oncology Models competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Preclinical Oncology Models market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Preclinical Oncology Models.
Chapter 13, to describe Preclinical Oncology Models research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Preclinical Oncology Models
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Preclinical Oncology Models by Type
- 1.3.1 Overview: Global Preclinical Oncology Models Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Preclinical Oncology Models Consumption Value Market Share by Type in 2022
- 1.3.3 Genetically Engineered Mouse Models (GEMMs)
- 1.3.4 Cell Line-derived Xenografts (CDX)
- 1.3.5 Patient-derived Xenografts (PDX)
- 1.3.6 Others
- 1.4 Global Preclinical Oncology Models Market by Application
- 1.4.1 Overview: Global Preclinical Oncology Models Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Pharmaceutical
- 1.4.3 Biological Experiments
- 1.4.4 Others
- 1.5 Global Preclinical Oncology Models Market Size & Forecast
- 1.6 Global Preclinical Oncology Models Market Size and Forecast by Region
- 1.6.1 Global Preclinical Oncology Models Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Preclinical Oncology Models Market Size by Region, (2018-2029)
- 1.6.3 North America Preclinical Oncology Models Market Size and Prospect (2018-2029)
- 1.6.4 Europe Preclinical Oncology Models Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Preclinical Oncology Models Market Size and Prospect (2018-2029)
- 1.6.6 South America Preclinical Oncology Models Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Preclinical Oncology Models Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 Aragen Bioscience
- 2.1.1 Aragen Bioscience Details
- 2.1.2 Aragen Bioscience Major Business
- 2.1.3 Aragen Bioscience Preclinical Oncology Models Product and Solutions
- 2.1.4 Aragen Bioscience Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Aragen Bioscience Recent Developments and Future Plans
- 2.2 Vivopharm
- 2.2.1 Vivopharm Details
- 2.2.2 Vivopharm Major Business
- 2.2.3 Vivopharm Preclinical Oncology Models Product and Solutions
- 2.2.4 Vivopharm Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Vivopharm Recent Developments and Future Plans
- 2.3 Bioduro
- 2.3.1 Bioduro Details
- 2.3.2 Bioduro Major Business
- 2.3.3 Bioduro Preclinical Oncology Models Product and Solutions
- 2.3.4 Bioduro Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Bioduro Recent Developments and Future Plans
- 2.4 Crown Bioscience
- 2.4.1 Crown Bioscience Details
- 2.4.2 Crown Bioscience Major Business
- 2.4.3 Crown Bioscience Preclinical Oncology Models Product and Solutions
- 2.4.4 Crown Bioscience Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Crown Bioscience Recent Developments and Future Plans
- 2.5 Charles River
- 2.5.1 Charles River Details
- 2.5.2 Charles River Major Business
- 2.5.3 Charles River Preclinical Oncology Models Product and Solutions
- 2.5.4 Charles River Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Charles River Recent Developments and Future Plans
- 2.6 Champion Oncology
- 2.6.1 Champion Oncology Details
- 2.6.2 Champion Oncology Major Business
- 2.6.3 Champion Oncology Preclinical Oncology Models Product and Solutions
- 2.6.4 Champion Oncology Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Champion Oncology Recent Developments and Future Plans
- 2.7 Envigo
- 2.7.1 Envigo Details
- 2.7.2 Envigo Major Business
- 2.7.3 Envigo Preclinical Oncology Models Product and Solutions
- 2.7.4 Envigo Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Envigo Recent Developments and Future Plans
- 2.8 Genoway Sa
- 2.8.1 Genoway Sa Details
- 2.8.2 Genoway Sa Major Business
- 2.8.3 Genoway Sa Preclinical Oncology Models Product and Solutions
- 2.8.4 Genoway Sa Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Genoway Sa Recent Developments and Future Plans
- 2.9 Hera Biolabs
- 2.9.1 Hera Biolabs Details
- 2.9.2 Hera Biolabs Major Business
- 2.9.3 Hera Biolabs Preclinical Oncology Models Product and Solutions
- 2.9.4 Hera Biolabs Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Hera Biolabs Recent Developments and Future Plans
- 2.10 Mi Bioresearch
- 2.10.1 Mi Bioresearch Details
- 2.10.2 Mi Bioresearch Major Business
- 2.10.3 Mi Bioresearch Preclinical Oncology Models Product and Solutions
- 2.10.4 Mi Bioresearch Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Mi Bioresearch Recent Developments and Future Plans
- 2.11 Pharmatest Services
- 2.11.1 Pharmatest Services Details
- 2.11.2 Pharmatest Services Major Business
- 2.11.3 Pharmatest Services Preclinical Oncology Models Product and Solutions
- 2.11.4 Pharmatest Services Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Pharmatest Services Recent Developments and Future Plans
- 2.12 Taconic Biosciences
- 2.12.1 Taconic Biosciences Details
- 2.12.2 Taconic Biosciences Major Business
- 2.12.3 Taconic Biosciences Preclinical Oncology Models Product and Solutions
- 2.12.4 Taconic Biosciences Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Taconic Biosciences Recent Developments and Future Plans
- 2.13 The Jackson Laboratory
- 2.13.1 The Jackson Laboratory Details
- 2.13.2 The Jackson Laboratory Major Business
- 2.13.3 The Jackson Laboratory Preclinical Oncology Models Product and Solutions
- 2.13.4 The Jackson Laboratory Preclinical Oncology Models Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 The Jackson Laboratory Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Preclinical Oncology Models Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Preclinical Oncology Models by Company Revenue
- 3.2.2 Top 3 Preclinical Oncology Models Players Market Share in 2022
- 3.2.3 Top 6 Preclinical Oncology Models Players Market Share in 2022
- 3.3 Preclinical Oncology Models Market: Overall Company Footprint Analysis
- 3.3.1 Preclinical Oncology Models Market: Region Footprint
- 3.3.2 Preclinical Oncology Models Market: Company Product Type Footprint
- 3.3.3 Preclinical Oncology Models Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Preclinical Oncology Models Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Preclinical Oncology Models Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Preclinical Oncology Models Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Preclinical Oncology Models Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Preclinical Oncology Models Consumption Value by Type (2018-2029)
- 6.2 North America Preclinical Oncology Models Consumption Value by Application (2018-2029)
- 6.3 North America Preclinical Oncology Models Market Size by Country
- 6.3.1 North America Preclinical Oncology Models Consumption Value by Country (2018-2029)
- 6.3.2 United States Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 6.3.3 Canada Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Preclinical Oncology Models Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Preclinical Oncology Models Consumption Value by Type (2018-2029)
- 7.2 Europe Preclinical Oncology Models Consumption Value by Application (2018-2029)
- 7.3 Europe Preclinical Oncology Models Market Size by Country
- 7.3.1 Europe Preclinical Oncology Models Consumption Value by Country (2018-2029)
- 7.3.2 Germany Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 7.3.3 France Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 7.3.5 Russia Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 7.3.6 Italy Preclinical Oncology Models Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Preclinical Oncology Models Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Preclinical Oncology Models Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Preclinical Oncology Models Market Size by Region
- 8.3.1 Asia-Pacific Preclinical Oncology Models Consumption Value by Region (2018-2029)
- 8.3.2 China Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 8.3.3 Japan Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 8.3.5 India Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 8.3.7 Australia Preclinical Oncology Models Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Preclinical Oncology Models Consumption Value by Type (2018-2029)
- 9.2 South America Preclinical Oncology Models Consumption Value by Application (2018-2029)
- 9.3 South America Preclinical Oncology Models Market Size by Country
- 9.3.1 South America Preclinical Oncology Models Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Preclinical Oncology Models Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Preclinical Oncology Models Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Preclinical Oncology Models Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Preclinical Oncology Models Market Size by Country
- 10.3.1 Middle East & Africa Preclinical Oncology Models Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Preclinical Oncology Models Market Size and Forecast (2018-2029)
- 10.3.4 UAE Preclinical Oncology Models Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Preclinical Oncology Models Market Drivers
- 11.2 Preclinical Oncology Models Market Restraints
- 11.3 Preclinical Oncology Models Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
- 11.5 Influence of COVID-19 and Russia-Ukraine War
- 11.5.1 Influence of COVID-19
- 11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
- 12.1 Preclinical Oncology Models Industry Chain
- 12.2 Preclinical Oncology Models Upstream Analysis
- 12.3 Preclinical Oncology Models Midstream Analysis
- 12.4 Preclinical Oncology Models Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Preclinical Oncology Models. Industry analysis & Market Report on Preclinical Oncology Models is a syndicated market report, published as Global Preclinical Oncology Models Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Preclinical Oncology Models market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
